Reimagining medicine: Novartis’ breakthrough therapies
With a market cap of more than $200 billion, Novartis is one of the largest pharmaceutical companies in the world and a leader in developing trusted innovative therapies to improve and prolong people’s lives. Under the visionary leadership of CEO Vas Narasimhan, Novartis has achieved extraordinary breakthroughs in gene, cell and other transformative therapies. Vas Narasimhan, discusses these key developments, and their implications with Magellan’s Chairman and Chief Investment Officer, Hamish Douglass.
Never miss an episode
New episodes of 'Magellan - In The Know' will be published on the last Tuesday of each month. We seek to bring you timely, unique and thought-provoking insights to help you make sense of today’s investment landscape. We will connect with colleagues and outside experts, including CEOs of stocks we hold and leading global consultants in economics, politics and risk. Click follow to be the first to receive it each month.
MORE ON Equities
Buy Hold Sell: 5 stocks riding the red-hot energy sector
Morgans’ 12 large-cap best ideas - June 2022
Livewire readers’ 20 most-tipped stocks to beat inflation
Money isn't everything
1 topic
1 contributor mentioned